<産業資料/調査レポートの題名> 2022年6月19日

遺伝子パネルの世界市場:製品別、地域別


◆英文タイトル:Gene Panel Market by Product and Geography - Forecast and Analysis 2020-2024

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Value Chain Analysis
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Small panel testing – Market size and forecast 2019-2024
• Large panel testing – Market size and forecast 2019-2024
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Increasing number of collaborations
• Rising use of direct-to-consumer tests
• Use of gene panels to identify potential side effects in patients
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agilent Technologies Inc.
• ArcherDx Inc.
• BGI Genomics Co. Ltd.
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd.
• GENEWIZ Inc.
• Novogene Corp.
• Personalis Inc.
• QIAGEN NV
• Thermo Fisher Scientific Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key product offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Small panel testing – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Small panel testing – Year-over-year growth 2020-2024 (%)
Exhibit 22: Large panel testing – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Large panel testing – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Agilent Technologies Inc. – Vendor overview
Exhibit 45: Agilent Technologies Inc. – Business segments
Exhibit 46: Agilent Technologies Inc. – Organizational developments
Exhibit 47: Agilent Technologies Inc. – Geographic focus
Exhibit 48: Agilent Technologies Inc. – Segment focus
Exhibit 49: Agilent Technologies Inc. – Key offerings
Exhibit 50: ArcherDx Inc. – Vendor overview
Exhibit 51: ArcherDx Inc. – Product segments
Exhibit 52: ArcherDx Inc. – Organizational developments
Exhibit 53: ArcherDx Inc. – Key offerings
Exhibit 54: BGI Genomics Co. Ltd. – Vendor overview
Exhibit 55: BGI Genomics Co. Ltd. – Product segments
Exhibit 56: BGI Genomics Co. Ltd. – Organizational developments
Exhibit 57: BGI Genomics Co. Ltd. – Key offerings
Exhibit 58: Eurofins Scientific SE – Vendor overview
Exhibit 59: Eurofins Scientific SE – Business segments
Exhibit 60: Eurofins Scientific SE – Organizational developments
Exhibit 61: Eurofins Scientific SE – Segment focus
Exhibit 62: Eurofins Scientific SE – Key offerings
Exhibit 63: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 64: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 65: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 66: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 67: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 68: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 69: GENEWIZ Inc. – Vendor overview
Exhibit 70: GENEWIZ Inc. – Product segments
Exhibit 71: GENEWIZ Inc. – Organizational developments
Exhibit 72: GENEWIZ Inc. – Key offerings
Exhibit 73: Novogene Corp. – Vendor overview
Exhibit 74: Novogene Corp. – Product segments
Exhibit 75: Novogene Corp. – Organizational developments
Exhibit 76: Novogene Corp. – Key offerings
Exhibit 77: Personalis Inc. – Vendor overview
Exhibit 78: Personalis Inc. – Business segments
Exhibit 79: Personalis Inc. – Organizational developments
Exhibit 80: Personalis Inc. – Key offerings
Exhibit 81: QIAGEN NV – Vendor overview
Exhibit 82: QIAGEN NV – Business segments
Exhibit 83: QIAGEN NV – Organizational developments
Exhibit 84: QIAGEN NV – Geographic focus
Exhibit 85: QIAGEN NV – Key offerings
Exhibit 86: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 87: Thermo Fisher Scientific Inc. – Business segments
Exhibit 88: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 89: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 90: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 91: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 92: Validation techniques employed for market sizing
Exhibit 93: Definition of market positioning of vendors


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark